These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 27245092)

  • 1. Evaluating the Role of Genetic Variants on first-line antiepileptic drug response in North India: Significance of SCN1A and GABRA1 Gene Variants in Phenytoin Monotherapy and its Serum Drug Levels.
    Baghel R; Grover S; Kaur H; Jajodia A; Rawat C; Srivastava A; Kushwaha S; Agarwal R; Sharma S; Kukreti R
    CNS Neurosci Ther; 2016 Sep; 22(9):740-57. PubMed ID: 27245092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between Genetic Polymorphism of
    Tang HX; Ho MD; Vu NP; Cao HV; Ngo VA; Nguyen VT; Nguyen TD; Nguyen TD
    Medicina (Kaunas); 2024 Apr; 60(4):. PubMed ID: 38674283
    [No Abstract]   [Full Text] [Related]  

  • 3. Association between two SCN1A polymorphisms and resistance to sodium channel blocking AEDs: a meta-analysis.
    Bao Y; Liu X; Xiao Z
    Neurol Sci; 2018 Jun; 39(6):1065-1072. PubMed ID: 29582177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SCN1A, SCN2A and SCN3A gene polymorphisms and responsiveness to antiepileptic drugs: a multicenter cohort study and meta-analysis.
    Haerian BS; Baum L; Kwan P; Tan HJ; Raymond AA; Mohamed Z
    Pharmacogenomics; 2013 Jul; 14(10):1153-66. PubMed ID: 23859570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association of SCN1A p.Thr1067Ala polymorphism with epilepsy risk and the response to antiepileptic drugs in Slovenian children and adolescents with epilepsy.
    Bertok S; Dolžan V; Goričar K; Podkrajšek KT; Battelino T; Rener-Primec Z
    Seizure; 2017 Oct; 51():9-13. PubMed ID: 28753467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SCN1A and SCN2A polymorphisms are associated with response to valproic acid in Chinese epilepsy patients.
    Shi L; Zhu M; Li H; Wen Z; Chen X; Luo J; Lin C; Zhang Z
    Eur J Clin Pharmacol; 2019 May; 75(5):655-663. PubMed ID: 30693367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SCN1AIVS5-91G>A polymorphism is associated with susceptibility to epilepsy but not with drug responsiveness.
    Kumari R; Lakhan R; Kumar S; Garg RK; Misra UK; Kalita J; Mittal B
    Biochimie; 2013 Jun; 95(6):1350-3. PubMed ID: 23466530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relevance of
    Fricke-Galindo I; Jung-Cook H; Martínez-Juárez IE; Monroy-Jaramillo N; Ortega-Vázquez A; Rojas-Tomé IS; Dorado P; Peñas-Lledó E; Llerena A; López-López M
    Pharmacogenomics; 2021 Oct; 22(15):983-996. PubMed ID: 34612084
    [No Abstract]   [Full Text] [Related]  

  • 9. Genetic profile of patients with epilepsy on first-line antiepileptic drugs and potential directions for personalized treatment.
    Grover S; Gourie-Devi M; Baghel R; Sharma S; Bala K; Gupta M; Narayanasamy K; Varma B; Gupta M; Kaur K; Talwar P; Kaur H; Giddaluru S; Sharma A; Brahmachari SK; Indian Genome Variation Consortium ; Kukreti R
    Pharmacogenomics; 2010 Jul; 11(7):927-41. PubMed ID: 20602612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SCN1A variations and response to multiple antiepileptic drugs.
    Yip TS; O'Doherty C; Tan NC; Dibbens LM; Suppiah V
    Pharmacogenomics J; 2014 Aug; 14(4):385-9. PubMed ID: 24342961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphic Variants of SCN1A and EPHX1 Influence Plasma Carbamazepine Concentration, Metabolism and Pharmacoresistance in a Population of Kosovar Albanian Epileptic Patients.
    Daci A; Beretta G; Vllasaliu D; Shala A; Govori V; Norata GD; Krasniqi S
    PLoS One; 2015; 10(11):e0142408. PubMed ID: 26555147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of SCN1A and GABA receptor genetic polymorphisms on carbamazepine tolerability and efficacy in Chinese patients with partial seizures: 2-year longitudinal clinical follow-up.
    Zhou BT; Zhou QH; Yin JY; Li GL; Qu J; Xu XJ; Liu D; Zhou HH; Liu ZQ
    CNS Neurosci Ther; 2012 Jul; 18(7):566-72. PubMed ID: 22591328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between SCN1A polymorphism rs3812718 and valproic acid resistance in epilepsy children: a case-control study and meta-analysis.
    Wang ZJ; Chen J; Chen HL; Zhang LY; Xu D; Jiang WT
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30413604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between SCN1A polymorphism and carbamazepine-resistant epilepsy.
    Abe T; Seo T; Ishitsu T; Nakagawa T; Hori M; Nakagawa K
    Br J Clin Pharmacol; 2008 Aug; 66(2):304-7. PubMed ID: 18489610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of SCN1A, SCN2A and ABCC2 gene polymorphisms with the response to antiepileptic drugs in Chinese Han patients with epilepsy.
    Ma CL; Wu XY; Zheng J; Wu ZY; Hong Z; Zhong MK
    Pharmacogenomics; 2014 Jul; 15(10):1323-36. PubMed ID: 25155934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of UGT2B7, SCN1A and CYP3A4 on the therapeutic response of sodium valproate treatment in children with generalized seizures.
    Feng W; Mei S; Zhu L; Yu Y; Yang W; Gao B; Wu X; Zhao Z; Fang F
    Seizure; 2018 May; 58():96-100. PubMed ID: 29679912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between SCN1A polymorphism and carbamazepine responsiveness in epilepsy: A meta-analysis.
    Zhang X; Liu J; Ye J
    Epilepsy Res; 2021 Oct; 176():106627. PubMed ID: 34218210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of CYP3A4/5 and ABCB1 genetic polymorphisms on carbamazepine metabolism and transport in Chinese patients with epilepsy treated with carbamazepine in monotherapy and bitherapy.
    Wang P; Yin T; Ma HY; Liu DQ; Sheng YH; Wang C; Zhou BT
    Epilepsy Res; 2015 Nov; 117():52-7. PubMed ID: 26421491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GABRG2, rs211037 is associated with epilepsy susceptibility, but not with antiepileptic drug resistance and febrile seizures.
    Balan S; Sathyan S; Radha SK; Joseph V; Radhakrishnan K; Banerjee M
    Pharmacogenet Genomics; 2013 Nov; 23(11):605-10. PubMed ID: 24061200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential implication of SCN1A and CYP3A5 genetic variants on antiepileptic drug resistance among Egyptian epileptic children.
    Abo El Fotoh WM; Abd El Naby SA; Habib MS; ALrefai AA; Kasemy ZA
    Seizure; 2016 Oct; 41():75-80. PubMed ID: 27498208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.